Home
>
National Drug Code (NDC)
>
Ciprofloxacin
Ciprofloxacin - 62037-942-30 - (Ciprofloxacin)
Drug Information of Ciprofloxacin
| Product NDC: | 62037-942 |
| Proprietary Name: | Ciprofloxacin |
| Non Proprietary Name: | Ciprofloxacin |
| Active Ingredient(s): | 212.6; 287.5 mg/1; mg/1 & nbsp; Ciprofloxacin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ciprofloxacin
| Product NDC: | 62037-942 |
| Labeler Name: | Watson Pharma, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077417 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101130 |
Package Information of Ciprofloxacin
| Package NDC: | 62037-942-30 |
| Package Description: | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (62037-942-30) |
NDC Information of Ciprofloxacin
| NDC Code | 62037-942-30 |
| Proprietary Name | Ciprofloxacin |
| Package Description | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (62037-942-30) |
| Product NDC | 62037-942 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ciprofloxacin |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20101130 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Pharma, Inc. |
| Substance Name | CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE |
| Strength Number | 212.6; 287.5 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient],Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |
